Immunization With a Combination of Four Recombinant Brucella abortus Proteins Omp16, Omp19, Omp28, and L7/L12 Induces T Helper 1 Immune Response Against Virulent B. abortus 544 Infection in BALB/c Mice

A combined subunit vaccine comprising BP26, Omp25 and L7/L12 against brucellosis

(2020) Sonal Gupta et al.   Pathogens and Disease

Immunogenicity and protective response induced by recombinant Brucella abortus proteins Adk, SecB and combination of these two recombinant proteins against a virulent strain B. abortus 544 infection in BALB/c mice

(2020) Tran Xuan Ngoc Huy et al.   MICROBIAL PATHOGENESIS

Substantial Protective Immunity Conferred by a Combination of Brucella abortus Recombinant Proteins against Brucella abortus 544 Infection in BALB/c Mice

(2019) Lauren Togonon Arayan et al.   JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY

Interleukin 6 (IL-6) promotes Brucella abortus clearance by controlling bactericidal activity of macrophages and CD8+ T cell differentiation

(2019) Huynh Tan Hop et al.   INFECTION AND IMMUNITY

Immunization of BALB/c mice with a combination of four recombinant Brucella abortus proteins, AspC, Dps, InpB and Ndk, confers a marked protection against a virulent strain of Brucella abortus

(2018) Huynh Tan Hop et al.   VACCINE

Activation of NF-kB-Mediated TNF-Induced Antimicrobial Immunity Is Required for the Efficient Brucella abortus Clearance in RAW 264.7 Cells

(2017) Huynh T. Hop et al.   Frontiers in Cellular and Infection Microbiology

Immunogenicity Analysis of a Novel Subunit Vaccine Candidate Molecule—Recombinant L7/L12 Ribosomal Protein of Brucella suis

(2016) Zhi-Qiang Du et al.   APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY

Recombinant L7/L12 protein entrapping PLGA (poly lactide-co-glycolide) micro particles protect BALB/c mice against the virulent B. abortus 544 infection

(2015) Damini Singh et al.   VACCINE

Immune response triggered by Brucella abortus following infection or vaccination

(2015) Elaine M.S. Dorneles et al.   VACCINE

Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization

(2015) Morteza Abkar et al.   VETERINARY RESEARCH COMMUNICATIONS

Host response to Brucella infection: review and future perspective

(2015) Mohamed G. Elfaki et al.   Journal of Infection in Developing Countries

IL-10: The Master Regulator of Immunity to Infection

(2014) Kevin N. Couper et al.   JOURNAL OF IMMUNOLOGY

Brucellaevasion of adaptive immunity

(2013) Anna Martirosyan et al.   Future Microbiology

A History of the Development ofBrucellaVaccines

(2013) Eric Daniel Avila-Calderón et al.   Biomed Research International

Recombinant vaccines and the development of new vaccine strategies

(2012) I.P. Nascimento et al.   BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH

Protective effects of recombinantBrucella abortusOmp28 against infection with a virulent strain ofBrucella abortus544 in mice

(2012) Jeong Ju Lim et al.   Journal of Veterinary Science

Invasive Escherichia coli vaccines expressing Brucella melitensis outer membrane proteins 31 or 16 or periplasmic protein BP26 confer protection in mice challenged with B. melitensis

(2012) V.K. Gupta et al.   VACCINE

Cloning and expression of the immunoreactive Brucella melitensis 28 kDa outer-membrane protein (Omp28) encoding gene and evaluation of the potential of Omp28 for clinical diagnosis of brucellosis

(2010) D. Thavaselvam et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Monocyte Chemoattractant Protein-1 (MCP-1): An Overview

(2009) Satish L. Deshmane et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Immunization with Recombinant Brucella Species Outer Membrane Protein Omp16 or Omp19 in Adjuvant Induces Specific CD4+ and CD8+ T Cells as Well as Systemic and Oral Protection against Brucella abortus Infection

(2008) K. A. Pasquevich et al.   INFECTION AND IMMUNITY